[开放获取]    从心身医学视角认识玫瑰痤疮

doi:10.35541/cjd.20230451

Abstract

Abstract: 【Abstract】 Rosacea is a psychosomatic disorder characterized by a distinct neurobiological etiology. It is prone to be comorbid with many neuropsychiatric conditions, and imposes a significant psychosocial burden. This article discusses the psychosomatic attributes of rosacea from neurological, psychiatric, social, and psychological perspectives, aiming to enhance dermatologists′ understanding of its psychosomatic nature.

Key words: Rosacea, Psychosomatic medicine, Neuropsychiatric diseases, Psychosocial factors

Jiang Xian, Song Deyu. Insights into rosacea from the perspective of psychosomatic medicine[J]. Chinese Journal of Dermatology, 2024, 57(2): 123-126.doi:10.35541/cjd.20230451

References ［44］

［1］	刘国艳, 高强, 张晓杰. 皮肤病患者心身现状与心理行为干预［J］. 国际皮肤性病学杂志, 2010,36（5）:279⁃281. doi: 10.3760/cma.j.issn.1673⁃4173.2010.05.013.
［2］	袁勇贵, 岳莹莹. 中国心身医学学科发展方向和机遇［J］. 东南大学学报（医学版）, 2020,39（5）:557⁃561. doi: 10.3969/j.issn.1671⁃6264.2020.05.001.
［3］	Whitlock FA. Psychosomatic aspects of rosacea［J］. Br J Dermatol, 1961,73:137⁃148. doi: 10.1111/j.1365⁃2133.1961.tb14422.x.
［4］	Jin R, Luo L, Zheng J. The trinity of skin: skin homeostasis as a neuro⁃endocrine⁃immune organ［J］. Life （Basel）, 2022,12（5）:725. doi: 10.3390/life12050725.
［5］	Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea［J］. J Investig Dermatol Symp Proc, 2011,15（1）:53⁃62. doi: 10.1038/jidsymp.2011.6.
［6］	Kim HB, Na EY, Yun SJ, et al. The effect of capsaicin on neuroinflammatory mediators of rosacea［J］. Ann Dermatol, 2022,34（4）:261⁃269. doi: 10.5021/ad.21.223.
［7］	Brinnel H, Friedel J, Caputa M, et al. Rosacea: disturbed defense against brain overheating［J］. Arch Dermatol Res, 1989,281（1）:66⁃72. doi: 10.1007/BF00424276.
［8］	Metzler⁃Wilson K, Toma K, Sammons DL, et al. Augmented supraorbital skin sympathetic nerve activity responses to symptom trigger events in rosacea patients［J］. J Neurophysiol, 2015,114（3）:1530⁃1537. doi: 10.1152/jn.00458.2015.
［9］	Wienholtz N, Christensen CE, Coskun H, et al. Infusion of pituitary adenylate cyclase⁃activating polypeptide⁃38 in patients with rosacea induces flushing and facial edema that can be attenuated by sumatriptan［J］. J Invest Dermatol, 2021,141（7）:1687⁃1698. doi: 10.1016/j.jid.2021.02.002.
［10］	Liu Y, Xu Y, Guo Z, et al. Identifying the neural basis for rosacea using positron emission tomography⁃computed tomography cerebral functional imaging analysis: a cross⁃sectional study［J］. Skin Res Technol, 2022,28（5）:708⁃713. doi: 10.1111/srt.13171.
［11］	Wienholtz N, Christensen CE, Zhang DG, et al. Clinical characteristics of combined rosacea and migraine［J］. Front Med （Lausanne）, 2022,9:1026447. doi: 10.3389/fmed.2022.1026447.
［12］	Sinikumpu SP, Vähänikkilä H, Jokelainen J, et al. Male patients with rosacea have increased risk for migraine: a population⁃based study［J］. Br J Dermatol, 2021,185（5）:1058⁃1061. doi: 10.1111/bjd.20578.
［13］	Egeberg A, Hansen PR, Gislason GH, et al. Exploring the association between rosacea and parkinson disease: a danish nationwide cohort study［J］. JAMA Neurol, 2016,73（5）:529⁃534. doi: 10.1001/jamaneurol.2016.0022.
［14］	Mathieu RJ, Guido N, Ibler E, et al. Rosacea and subsequent diagnosis for Parkinson′s disease: a large, urban, single center, US patient population retrospective study［J］. J Eur Acad Dermatol Venereol, 2018,32（4）:e141⁃e144. doi: 10.1111/jdv. 14638.
［15］	Egeberg A, Hansen PR, Gislason GH, et al. Patients with rosacea have increased risk of dementia［J］. Ann Neurol, 2016,79（6）:921⁃928. doi: 10.1002/ana.24645.
［16］	Long J, Li J, Yuan X, et al. Potential association between rosacea and cancer: a study in a medical center in southern China［J］. J Dermatol, 2019,46（7）:570⁃576. doi: 10.1111/1346⁃8138.14918.
［17］	Woo YR, Han YJ, Kim HS, et al. Updates on the risk of neuropsychiatric and gastrointestinal comorbidities in rosacea and its possible relationship with the Gut⁃Brain⁃Skin Axis［J］. Int J Mol Sci, 2020,21（22）:8427. doi: 10.3390/ijms21228427.
［18］	Lukaviciute L, Ganceviciene R, Navickas P, et al. Anxiety, depression, and suicidal ideation amongst patients with facial dermatoses （acne, rosacea, perioral dermatitis, and folliculitis） in Lithuania［J］. Dermatology, 2020,236（4）:314⁃322. doi: 10. 1159/000506627.
［19］	Chang HC, Huang YC, Lien YJ, et al. Association of rosacea with depression and anxiety: a systematic review and meta⁃analysis［J］. J Affect Disord, 2022,299:239⁃245. doi: 10.1016/j.jad.2021.12.008.
［20］	Wang Z, Xie H, Gong Y, et al. Relationship between rosacea and sleep［J］. J Dermatol, 2020,47（6）:592⁃600. doi: 10.1111/1346⁃8138.15339.
［21］	Aktaş Karabay E, Karşıyakalı N, Karabay E. Evaluation of sexual functions in female rosacea patients: a prospective, case⁃control study［J］. Int J Impot Res, 2020,32（6）:628⁃634. doi: 10.1038/s41443⁃020⁃0275⁃z.
［22］	Scharschmidt TC, Yost JM, Truong SV, et al. Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment［J］. Arch Dermatol, 2011,147（1）:123⁃126. doi: 10.1001/archdermatol.2010.413.
［23］	Li M, Tao M, Zhang Y, et al. Neurogenic rosacea could be a small fiber neuropathy［J］. Front Pain Res （Lausanne）, 2023,4:1122134. doi: 10.3389/fpain.2023.1122134.
［24］	Wu Y, Fu C, Zhang W, et al. The dermatology life quality index （DLQI） and the hospital anxiety and depression （HADS） in Chinese rosacea patients［J］. Psychol Health Med, 2018,23（4）:369⁃374. doi: 10.1080/13548506.2017.1361540.
［25］	Yang F, Wang L, Shucheng H, et al. Differences in clinical characteristics of rosacea across age groups: a retrospective study of 840 female patients［J］. J Cosmet Dermatol, 2023,22（3）:949⁃957. doi: 10.1111/jocd.15470.
［26］	Chen M, Deng Z, Huang Y, et al. Prevalence and risk factors of anxiety and depression in rosacea patients: a cross⁃sectional study in China［J］. Front Psychiatry, 2021,12:659171. doi: 10.3389/fpsyt.2021.659171.
［27］	李健, 宋志强. 玫瑰痤疮面部潮红与红斑新认识［J］. 中华皮肤科杂志, 2021,54（4）:360⁃363. doi: 10.35541/cjd.20190920.
［28］	Huynh TT. Burden of Disease: The psychosocial impact of rosacea on a patient′s quality of life［J］. Am Health Drug Benefits, 2013,6（6）:348⁃354.
［29］	Li J, Tang JY, Fu J, et al. Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety/depression［J］. J Dermatol, 2022,49（11）:1139⁃1147. doi: 10.1111/1346⁃8138.16525.
［30］	Drummond PD, Su D. Blushing in rosacea sufferers［J］. J Psychosom Res, 2012,72（2）:153⁃158. doi: 10.1016/j.jpsychores. 2011.09.002.
［31］	Halioua B, Cribier B, Frey M, et al. Feelings of stigmatization in patients with rosacea［J］. J Eur Acad Dermatol Venereol, 2017,31（1）:163⁃168. doi: 10.1111/jdv.13748.
［32］	Böhm D, Schwanitz P, Stock Gissendanner S, et al. Symptom severity and psychological sequelae in rosacea: results of a survey［J］. Psychol Health Med, 2014,19（5）:586⁃591. doi: 10. 1080/13548506.2013.841968.
［33］	Hassan S, Mohammed TO, Hoenig LJ. Bardolph′s rosacea: skin disorders that define personality in Shakespeare′s plays［J］. Clin Dermatol, 2019,37（5）:600⁃603. doi: 10.1016/j.clindermatol.2019. 07.021.
［34］	Dirschka T, Micali G, Papadopoulos L, et al. Perceptions on the psychological impact of facial erythema associated with rosacea: results of international survey［J］. Dermatol Ther （Heidelb）, 2015,5（2）:117⁃127. doi: 10.1007/s13555⁃015⁃0077⁃2.
［35］	Karlsson E, Berg M, Arnetz BB. Rosacea and personality［J］. Acta Derm Venereol, 2004,84（1）:76⁃77. doi: 10.1080/0001555 0310005799.
［36］	杨赛, 谢红付, 邓宇瑄, 等. A型性格与玫瑰痤疮的相关性研究［J］. 临床皮肤科杂志, 2014,43（12）:707⁃709.
［37］	Alinia H, Moradi Tuchayi S, Farhangian ME, et al. Rosacea patients seeking advice: qualitative analysis of patients′ posts on a rosacea support forum［J］. J Dermatolog Treat, 2016,27（2）:99⁃102. doi: 10.3109/09546634.2015.1133881.
［38］	Riddoch LH. It takes one to know one: exploring patient dialogue on rosacea web⁃based platforms and their potential for significant harm［J］. J Dermatolog Treat, 2019,30（1）:52⁃62. doi: 10.1080/09546634.2018.1468067.
［39］	Johnston SA, Krasuska M, Millings A, et al. Experiences of rosacea and its treatment: an interpretative phenomenological analysis［J］. Br J Dermatol, 2018,178（1）:154⁃160. doi: 10.1111/bjd.15780.
［40］	Carter C, Martin K, Gordon C, et al. Exploring the lived experience of women with rosacea: visible difference and psychological impact［J］. Br J Dermatol, 2022,186（2）:366⁃367. doi: 10.1111/bjd.20768.
［41］	Wang B, Huang Y, Tang Y, et al. Paroxetine is an effective treatment for refractory erythema of rosacea: primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial［J］. J Am Acad Dermatol, 2023,88（6）:1300⁃1307. doi: 10.1016/j.jaad.2023.01.044.
［42］	中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业组. A型肉毒毒素皮内注射治疗玫瑰痤疮持久性红斑及潮红专家共识［J］. 中华皮肤科杂志, 2023,56（1）:16⁃21. doi: 10.35541/cjd.20220390.
［43］	Drott C, Claes G, Olsson⁃Rex L, et al. Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy［J］. Br J Dermatol, 1998,138（4）:639⁃643. doi: 10.1046/j.1365⁃2133. 1998.02176.x.
［44］	Magid M, Reichenberg JS. An evidence⁃based approach to starting a psychodermatology clinic［J］. JAMA Dermatol, 2020,156（6）:617⁃618. doi: 10.1001/jamadermatol.2020.0393.

[1]	Zhang Yue, Tao Meng, Li Min, Jiang Peiyu, Liu Yunyi, Liu Yixuan, Pan Ruoxin, Xu Yang. Severity assessment criteria for rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 182-185.
[2]	Pan Ruoxin, Gu Duoduo, Zhang Yue, Li Min, Tao Meng, Xu Yang. Metabolomics in rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 178-181.
[3]	Wei Ziyu, Yang Yong. Role of ion channels in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 174-177.
[4]	Liu Tingwei, Meng Xiaoqi, Gu Duoduo, Pan Ruoxin, Zhang Yue, Xu Yang. Advances in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 186-190.
[5]	Li Ji, Xie Hongfu. How to avoid misdiagnosis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 119-122.
[6]	Na Jun, Li Ruoyu, Zhong Shaomin, Yang Li, Wu Yan. Diagnosis and treatment of rosacea in the real world: a survey on the current status [J]. Chinese Journal of Dermatology, 2024, 57(2): 127-133.
[7]	Ma Guangrong, Xie Hongfu, Liu Jiashuang, Zhou Zhonglian, Zou Songqi, Huang Yingxue, Li Ji. Small intestinal bacterial overgrowth in patients with rosacea: prevalence and clinical features [J]. Chinese Journal of Dermatology, 2024, 57(2): 134-140.
[8]	Zhang Xiaodong, Wang Manya, Zhu Yingjie, Luo Tiande, Liu Xiaoming. Application of fluorescence staining in the detection of Demodex mites in the facial skin [J]. Chinese Journal of Dermatology, 2023, 56(8): 766-769.
[9]	Tao Meng, Li Min, Liu Yixuan, Liu Yunyi, Jiang Peiyu, Zhang Jiawen, Nan Yuqing, Xu Yang. Correlation between rosacea and neuropsychiatric diseases [J]. Chinese Journal of Dermatology, 2023, 56(7): 693-697.
[10]	Mi Shuhong, Yu Yanqin, Hao Jinqi, Li Wei, Zhang Yang, Jia Ximei, Huang Yuxian, Sun Huaiyu, Shi Jihai. Analysis of imaging characteristics of papulopustular rosacea by high-frequency ultrasound combined with color Doppler flow imaging [J]. Chinese Journal of Dermatology, 2023, 56(6): 540-544.
[11]	Li Jiaqi, Ye Feng, Ju Qiang. Symbiotic homeostasis of Staphylococcus epidermidis is associated with common skin disorders [J]. Chinese Journal of Dermatology, 2023, 56(5): 459-462.
[12]	Li Rong, Zhang Jiaan, Chen Kun. Photoelectric therapy for rosacea [J]. Chinese Journal of Dermatology, 2023, 56(5): 468-470.
[13]	Wang Xiaoyan, Zhang Jiawen, Liu Yunyi, Liu Yixuan, Jiang Peiyu, Li Min, Tao Meng, Xu Yang. Skin imaging and noninvasive measurements of rosacea [J]. Chinese Journal of Dermatology, 2023, 56(4): 361-364.
[14]	Chen Lianghong, Sun Yan, Wang Jingyu, Wu Yan. Benvitimod for the treatment of dermatoses [J]. Chinese Journal of Dermatology, 2023, 0(2): 20210875-e20210875.
[15]	Sun Jing, Xu Yingnan, Lin Tong, Xue Jinsong. Analysis of clinical treatment outcomes of ocular lesions in 28 cases of severe ocular rosacea [J]. Chinese Journal of Dermatology, 2023, 56(2): 142-145.

Insights into rosacea from the perspective of psychosomatic medicine

PDF

Knowledge

Abstract

Cite this article

share this article

References ［44］

Related Articles 15

Metrics

Comments

Recommended 10